Investor Resources Home

Webcast ImageWebcast - Replay
Heron Therapeutics Inc at JMP Securities 2016 Life Sciences Conference
06/22/16 at 2:30 p.m. ET
At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents. Our goal is to build on therapeutics with well-known pharmacology by improving their safety and efficacy as well as broadening their potential field of use.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$17.20
Change (%) Stock is Down 0.94 (5.18%)
Volume499,815
Data as of 06/24/16 4:00 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
06/22/16
Download Documentation Corporate Presentation June 22, 2016

Recent News

More >>
DateTitle 
06/22/16Heron Therapeutics Announces Appointment of Christian Waage to Board of DirectorsPrinter Friendly Version
06/15/16Heron Therapeutics to Present at the JMP Securities Life Sciences ConferencePrinter Friendly Version
05/05/16Heron Therapeutics Announces First Quarter 2016 Financial Results and Recent Corporate ProgressPrinter Friendly Version
04/18/16Heron Therapeutics Provides Update on FDA Review of SUSTOL® NDAPrinter Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.